20180410: ICC NF155 IgG in CMT patients

Objectives: To test CMT patients for IgG positivity towards NF155.

Samples: 

NAME (Diagnosis)CODERESULTS IgG
Gerardo Martínez Martínez (CMT)
213-18-
Neus Assens Serra (CMT1A)
18-622-
Roger Marginet Assens (CMT1A)18-623-
Neuromus_184 (H. La Fe) (CMT)
18-624-
Neuromus_185 (H. La Fe) (CMT)
18-625-
Neuromus_194 (H. La Fe) (CMT)18-626-
Neuromus_195 (H. La Fe) (CMT)18-627-
Neuromus_196 (H. La Fe) (CMT)18-628-
Neuromus_202 (H. La Fe) (CMT)18-629-
Neuromus_203 (H. La Fe) (CMT)18-630-
Neuromus_204 (H. La Fe) (CMT)18-631-
Neuromus_218 (H. La Fe) (CMT)18-632-
Neuromus_219 (H. La Fe) (CMT)18-633-
Neuromus_258 (H. La Fe) (CMT)18-634-
Neuromus_316 (H. La Fe) (CMT)18-635-
Control negatiu-
Control positiu15-195+

NF155 ICC:

  • HEKs 293 Cells Transfection: 2018.01.16
  • Blocking solution: 5% goat serum in PBS.
  • Patient’s sera diluted 1/100 for IgG with 5% goat serum in PBS.
  • Primary antibody: AF3235 diluted 1/1000.
  • Secondary antibodies: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
  • Vectashield mounting medium.

Results: all samples were negative for IgG towards NF155.

 

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.